Efficacy and safety of reduced dose of PD-1 inhibitor combined with CD19-CAR-T on B-cell non-Hodgkin lymphoma patients with high expression of PD-1 in peripheral blood.
- VernacularTitle:CAR-T19细胞联合减低剂量PD-1抑制剂治疗PD-1高表达B细胞淋巴瘤临床安全性初探
- Author:
Jia WANG
;
Qi DENG
;
Yan Yu JIANG
;
Rui ZHANG
;
Hai bo ZHU
;
Juan Xia MENG
;
Ming Feng ZHAO
;
Yu Ming LI
- Publication Type:Journal Article
- From: Chinese Journal of Hematology 2018;39(10):862-865
- CountryChina
- Language:Chinese